You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬邦德(002082.SZ):子公司石杉鹼甲控釋片獲得倫理批件

格隆匯6月30日丨萬邦德(002082.SZ)公佈,公司全資子公司萬邦德製藥集團有限公司的2.2類新藥石杉鹼甲控釋片治療輕中度阿爾茨海默病型癡呆的關鍵註冊臨牀試驗近日獲得了組長單位首都醫科大學宣武醫院倫理審查委員會的審查批件,批準項目開展。

石杉鹼甲控釋片是公司自主研發的用於治療輕中度阿爾茨海默病型癡呆的2.2類新藥,採用雙相控釋技術,平緩藥物釋放峯谷曲線,並延長藥物體內釋放時間,實現快速起效,減少不良反應,提升給藥劑量與良好的安全性。同時,控釋技術實現每天一次給藥,減少次數提高患者依從性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account